Racial differences in the outcomes of IBD hospitalizations: a national population-based study.
Black patients
Crohn’s disease
Inflammatory bowel disease
Racial differences
Ulcerative colitis
White patients
Journal
International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
accepted:
18
10
2021
pubmed:
26
10
2021
medline:
19
1
2022
entrez:
25
10
2021
Statut:
ppublish
Résumé
There are scarce data describing the outcomes of hospitalized patients admitted with inflammatory bowel disease (IBD) stratified by race. In this retrospective cohort study, we evaluated the difference in outcomes between adult white and black patients hospitalized with a principal diagnosis of inflammatory bowel disease. Data were obtained from the 2016 and 2017 National Inpatient Sample (NIS) database. Our primary outcome was inpatient mortality while the secondary outcomes were hospital length of stay (LOS), total hospital charges (THC), red blood cell (RBC) transfusion, diagnosis of bowel perforation, and severe sepsis with septic shock. We conducted the analysis using STATA software. We used propensity-matched multivariate regression analysis to adjust for potential confounders. Among 71 million hospital hospitalizations, we found 177,574 hospitalizations with a principal diagnosis of IBD, with 24,635 (13.9%) for black patients, 124,899 (70.3%) for white patients, and 28,040 (15.8%) were for others. There was no significant difference in inpatient mortality for black vs white patients. Among secondary outcomes, white compared to black patients had increased odds of having a diagnosis of bowel perforation when admitted with a diagnosis of IBD while there was no difference in the odds of developing septic shock. White patients admitted with a diagnosis of UC were also found to have increased total LOS and THC. White patients hospitalized with a principal diagnosis of IBD had no difference in inpatient mortality or septic shock but had worse outcomes such as increased odds of bowel perforation compared to black patients.
Identifiants
pubmed: 34694440
doi: 10.1007/s00384-021-04052-z
pii: 10.1007/s00384-021-04052-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
221-229Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB (2016) Prevalence of inflammatory bowel disease among adults aged ≥18 years — United States, 2015. MMWR Morb Mortal Wkly Rep 65(42):1166–1169. https://doi.org/10.15585/mmwr.mm6542a3 . (PMID: 27787492)
doi: 10.15585/mmwr.mm6542a3
pubmed: 27787492
Hwang JM, Varma MG (2008) Surgery for inflammatory bowel disease. World J Gastroenterol 14(17):2678–2690. https://doi.org/10.3748/wjg.14.2678 . (PMID: 18461653; PMCID: PMC2709047)
doi: 10.3748/wjg.14.2678
pubmed: 18461653
pmcid: 2709047
Sewell JL, Yee HF Jr, Inadomi JM (2010) Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 16(2):204–207. https://doi.org/10.1002/ibd.21008 . (PMID: 19575353)
doi: 10.1002/ibd.21008
pubmed: 19575353
Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV Jr (2019) Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol 6(12):1756284819827692. https://doi.org/10.1177/1756284819827692 . (PMID: 30792818; PMCID: PMC6376543)
doi: 10.1177/1756284819827692
Veluswamy H, Suryawala K, Sheth A, Wells S, Salvatierra E, Cromer W, Chaitanya GV, Painter A, Patel M, Manas K, Zwank E, Boktor M, Baig K, Datti B, Mathis MJ, Minagar A, Jordan PA, Alexander JS (2010) African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol 9(10):104. https://doi.org/10.1186/1471-230X-10-104 . (PMID: 20828408; PMCID: PMC2944337)
Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM (1992) Crohn’s disease among ethnic groups in a large health maintenance organization. Gastroenterology 102(6):1940–1948. https://doi.org/10.1016/0016-5085(92)90317-r . (PMID: 1587413)
doi: 10.1016/0016-5085(92)90317-r
pubmed: 1587413
Vespa J, Medina L, Armstrong DM (2018) Demographic turning points for the United States: population projections for 2020 to 2060. Retrieved April 12, 2021, from https://www.census.gov/content/dam/Census/library/publications/2020/demo/p25-1144.pdf
Afzali A, Cross RK (2016) Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis 22(8):2023–2040. https://doi.org/10.1097/MIB.0000000000000835 . (PMID: 27379446)
doi: 10.1097/MIB.0000000000000835
pubmed: 27379446
Kaplan GG, Windsor JW (2021) The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18(1):56–66. https://doi.org/10.1038/s41575-020-00360-x . (Epub 2020 Oct 8 PMID: 33033392; PMCID: PMC7542092)
Xu F, Wheaton AG, Liu Y, Lu H, Greenlund KJ (2019) Hospitalizations for inflammatory bowel disease among Medicare fee-for-service beneficiaries — United States, 1999–2017. MMWR Morb Mortal Wkly Rep 68(49):1134–1138. https://doi.org/10.15585/mmwr.mm6849a2 . (PMID: 31830006; PMCID: PMC6919289)
doi: 10.15585/mmwr.mm6849a2
pubmed: 31830006
pmcid: 6919289
Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT (2000) Crohn’s disease: does race matter? The Mid-Atlantic Crohn’s Disease Study Group Am J Gastroenterol 95(2):479–483. https://doi.org/10.1111/j.1572-0241.2000.t01-1-01531.x . (PMID: 10685754)
Basu D, Lopez I, Kulkarni A, Sellin JH (2005) Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 100(10):2254–2261. https://doi.org/10.1111/j.1572-0241.2005.00233.x . (PMID: 16181378)
doi: 10.1111/j.1572-0241.2005.00233.x
pubmed: 16181378
Montgomery SR Jr, Butler PD, Wirtalla CJ, Collier KT, Hoffman RL, Aarons CB, Damrauer SM, Kelz RR (2018) Racial disparities in surgical outcomes of patients with inflammatory bowel disease. Am J Surg 215(6):1046–1050. https://doi.org/10.1016/j.amjsurg.2018.05.011 . (Epub 2018 May 12 PMID: 29803499; PMCID: PMC7764563)
Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV (2015) Racial disparities in readmission, complications, and procedures in children with Crohn’s disease. Inflamm Bowel Dis 21(4):801–808. https://doi.org/10.1097/MIB.0000000000000325 . (PMID: 25742396; PMCID: PMC4366277)
doi: 10.1097/MIB.0000000000000325
pubmed: 25742396
Nguyen GC, Chong CA, Chong RY (2014) National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis 8(4):288–295. https://doi.org/10.1016/j.crohns.2013.09.001 . (Epub 2013 Sep 24 PMID: 24074875)
doi: 10.1016/j.crohns.2013.09.001
pubmed: 24074875
Ojemolon PE, Shaka H, Edigin E, Gomez TMA, Eseaton P, Bello J, Azubuike C, Adekola OP (2020) Impact of diabetes mellitus on outcomes of patients with knee osteoarthritis who underwent knee arthroplasty: an analysis of the nationwide inpatient sample. Cureus 12(6). https://doi.org/10.7759/cureus.8902 . (PMID: 32742869; PMCID: PMC7389248)
Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163(3):262–270. https://doi.org/10.1093/aje/kwj047 . (Epub 2005 Dec 21 PMID: 16371515)
doi: 10.1093/aje/kwj047
pubmed: 16371515
Gunnells DJ Jr, Morris MS, DeRussy A, Gullick AA, Malik TA, Cannon JA, Hawn MT, Chu DI (2016) Racial disparities in readmissions for patients with inflammatory bowel disease (IBD) after colorectal surgery. J Gastrointest Surg 20(5):985–993. https://doi.org/10.1007/s11605-015-3068-9 . (Epub 2016 Jan 7 PMID: 26743885)
doi: 10.1007/s11605-015-3068-9
pubmed: 26743885
Walker C, Allamneni C, Orr J, Yun H, Fitzmorris P, Xie F, Malik TA (2018) Socioeconomic status and race are both Independently associated with increased hospitalization rate among Crohn’s disease patients. Sci Rep 8(1):4028. https://doi.org/10.1038/s41598-018-22429-z . (PMID: 29507339; PMCID: PMC5838155)
doi: 10.1038/s41598-018-22429-z
pubmed: 29507339
pmcid: 5838155
Braveman P, Gottlieb L (2014) The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep 129(Suppl 2):19–31. https://doi.org/10.1177/00333549141291S206 . (PMID: 24385661; PMCID: PMC3863696)
Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR (2009) Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 15(8):1233–1239. https://doi.org/10.1002/ibd.20883 . (PMID: 19177509; PMCID: PMC2799328)
doi: 10.1002/ibd.20883
pubmed: 19177509
Wang EC, Choe MC, Meara JG, Koempel JA (2004) Inequality of access to surgical specialty health care: why children with government-funded insurance have less access than those with private insurance in Southern California. Pediatrics 114(5):e584–e590. https://doi.org/10.1542/peds.2004-0210 . (PMID: 15520090)
doi: 10.1542/peds.2004-0210
pubmed: 15520090
Medicaid Access Study Group (1994) Access of Medicaid recipients to outpatient care. N Engl J Med 330(20):1426–1430. https://doi.org/10.1056/NEJM199405193302007 . (PMID: 8159198)
doi: 10.1056/NEJM199405193302007
Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS (2018) Lack of difference in treatment patterns and clinical outcomes between black and white patients with inflammatory bowel disease. Inflamm Bowel Dis 24(12):2634–2640. https://doi.org/10.1093/ibd/izy179 . (PMID:29788063;PMCID:PMC6262194)
doi: 10.1093/ibd/izy179
pubmed: 29788063
pmcid: 6262194
Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S (2008) Inflammatory bowel disease and African Americans: a systematic review. Inflamm Bowel Dis 14(7):960–967. https://doi.org/10.1002/ibd.20389 . (PMID: 18266229)
doi: 10.1002/ibd.20389
pubmed: 18266229
Nguyen GC, Bayless TM, Powe NR, Laveist TA, Brant SR (2007) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13(11):1408–1416. https://doi.org/10.1002/ibd.20200 . (PMID: 17567876)
doi: 10.1002/ibd.20200
pubmed: 17567876
Nguyen GC, Laveist TA, Gearhart S, Bayless TM, Brant SR (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4(12):1507–1513. https://doi.org/10.1016/j.cgh.2006.09.026 . Erratum In: Clin Gastroenterol Hepatol (2007) 5(6):765. (PMID: 17162242)
Cross RK, Jung C, Wasan S, Joshi G, Sawyer R, Roghmann MC (2006) Racial differences in disease phenotypes in patients with Crohn’s disease. Inflamm Bowel Dis 12(3):192–198. https://doi.org/10.1097/01.MIB.0000217767.98389.20 . (PMID: 16534420)
doi: 10.1097/01.MIB.0000217767.98389.20
pubmed: 16534420
Moore L, Gaffney K, Lopez R, Shen B (2012) Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study. Inflamm Bowel Dis 18(4):743–749. https://doi.org/10.1002/ibd.21796 . (Epub 2011 Jun 17 PMID: 21688351)
doi: 10.1002/ibd.21796
pubmed: 21688351
Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 101(5):1012–1023. https://doi.org/10.1111/j.1572-0241.2006.00504.x . (PMID: 16696785)
doi: 10.1111/j.1572-0241.2006.00504.x
pubmed: 16696785
Pola S, Patel D, Ramamoorthy S, McLemore E, Fahmy M, Rivera-Nieves J, Chang JT, Evans E, Docherty M, Talamini M, Sandborn WJ (2012) Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol 10(12):1315–1325.e4. https://doi.org/10.1016/j.cgh.2012.07.006 . (Epub 2012 Jul 24 PMID: 22835577; PMCID: PMC4226798)
Kugathasan S, Loizides A, Babusukumar U, McGuire E, Wang T, Hooper P, Nebel J, Kofman G, Noel R, Broeckel U, Tolia V (2005) Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn’s disease. Inflamm Bowel Dis 11(7):631–638. https://doi.org/10.1097/01.mib.0000171279.05471.21 . (PMID: 15973116)
doi: 10.1097/01.mib.0000171279.05471.21
pubmed: 15973116
Flasar MH, Johnson T, Roghmann MC, Cross RK (2008) Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis 14(1):13–19. https://doi.org/10.1002/ibd.20298 . (PMID: 17973305)
doi: 10.1002/ibd.20298
pubmed: 17973305
Makkar R, Bo S (2013) Colonoscopic perforation in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 9(9):573–83. (PMID: 24729766; PMCID: PMC3983974)
Navaneethan U, Kochhar G, Phull H, Venkatesh PG, Remzi FH, Kiran RP, Shen B (2012) Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients. J Crohns Colitis 6(4):470–475. https://doi.org/10.1016/j.crohns.2011.10.005 . (Epub 2011 Nov 17 PMID: 22398061)
doi: 10.1016/j.crohns.2011.10.005
pubmed: 22398061
Kaur M, Dalal RL, Shaffer S, Schwartz DA, Rubin DT (2020) Inpatient management of inflammatory bowel disease-related complications. Clin Gastroenterol Hepatol 18(6):1346–1355. https://doi.org/10.1016/j.cgh.2019.12.040 . (Epub 2020 Jan 9 PMID: 31927105)
doi: 10.1016/j.cgh.2019.12.040
pubmed: 31927105
Edigin E, Ojemolon PE, Eseaton PO, Jamal S, Shaka H, Akuna E, Asemota IR, Manadan A (2020) Systemic sclerosis is associated with increased inpatient mortality in patients admitted for acute coronary syndrome: analysis of the National Inpatient Sample. J Clin Rheumatol 1. https://doi.org/10.1097/RHU.0000000000001634 . (Epub ahead of print. PMID: 33264253)
Edigin E, Asotibe J, Eseaton PO, Busari OA, Achebe I, Kichloo A, Jamal S, Patel A (2021) Coexisting psoriasis is associated with an increased risk of hospitalization for patients with inflammatory bowel disease: an analysis of the National inpatient sample database. J Investig Med 69(4):857-62. https://doi.org/10.1136/jim-2020-001689 . (Epub ahead of print. PMID: 33361402)